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Interactionsbetween short modiﬁed peptide motifs and modular protein domains arecentral events
in cell signal-transduction. We determined interaction partners to all cytosolic tyrosine residues of
the four members of the ErbB-receptor family in an unbiased fashion by quantitative proteomics
using pull-down experiments with pairs of phosphorylated and nonphosphorylated synthetic
peptides. Each receptor had characteristic preferences for interacting proteins and most interaction
partners had multiple binding sites on each receptor. EGFR and ErbB4 had several docking sites for
Grb2, while ErbB3 was characterized by six binding sites for PI3K. We identiﬁed STAT5 as a direct
binding partner to EGFR and ErbB4 and discovered new recognition motifs for Shc and STAT5. The
overall pattern of interaction partners of EGFR and ErbB4 suggests similar roles during signaling
through theirrespectiveligands.Phosphorylation kineticsof severaltyrosine resideswasmeasured
by mass spectrometry and correlated with interaction partner preference. Our results demonstrate
that system-wide mapping of peptide–protein interactions sites is possible, and suggest shared and
unique roles of ErbB-receptor family members in downstream signaling.
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Introduction
Modiﬁcation-dependent protein–protein interactions between
domains and characteristic peptide motifs are key organizing
principles of signaling events in all organisms. For example,
speciﬁc, extended peptide sequences containing phosphotyr-
osine interact with cognate SH2 or PTB domains (Pawson and
Nash, 2003; Schlessinger and Lemmon, 2003; Pawson, 2004).
Consensus peptide sequences involved in recognition by
domains have been well studied using oriented peptide
libraries (Songyang et al, 1994), peptide arrays (Landgraf
et al, 2004) or phage display (Cesareni et al, 2002). Individual
interactions between activated tyrosine kinase receptors and
speciﬁc downstream signaling molecules have been investi-
gated using immunoprecipitation and detection of selected
proteins by Western blotting (see Olayioye et al, 2000 and
references therein). However, most of these methods lack
speciﬁcity for modiﬁcation-dependent interactions.
In the past, there have been several studies for large-scale
protein–protein interaction mapping in yeast (Ito et al, 2000,
2001; Uetz et al, 2000; Gavin et al, 2002; Ho et al, 2002) and in
higher organisms (Bouwmeester et al, 2004; Goehler et al,
2004) using the yeast two-hybrid system or tagging of full-
length proteins, followed by immunoprecipitation and mass
spectrometric identiﬁcation of bound partners. This work
provided important insights into protein interaction networks
but did not speciﬁcally address signal-dependent interactions.
However, to serve as a basis for systems biology, static and
dynamic,signal-dependent interactions need to be determined
in a comprehensive manner. Since protein–protein interac-
tions during signaling events occur in a controlled and ordered
way, proteins serving as nodes in interaction networks need to
provide distinct binding sites for the variety of interaction
partners, in response to different stimuli. In order to improve
our understanding of how interaction speciﬁcity of different
pathways is achieved, it is important to obtain an overview of
the intramolecular distribution of binding sites. Therefore,
there is a great need for methods that can determine
interactions at the resolution of single modiﬁcation sites and
with high-throughput. This would help in systematizing our
increasing knowledge of protein interaction networks and
signaling pathways.
Members of the ErbB-receptor family are expressed in many
different tissues and play a crucial role in cell proliferation and
differentiation. They are activated by ligand binding, which
leads to homo- or heterodimerization followed by transphos-
phorylation of characteristic tyrosines. This triggers down-
stream signaling cascades by recruitment of speciﬁc substrate
proteins.EGFR(ErbB1)andErbB4arefullyfunctionalreceptor
tyrosine kinases, whereas ErbB2 has no endogenous ligand
and ErbB3 has no functional kinase domain. Changes in
expression and aberrant activation, especially of EGFR and
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Article number: 2005.0008ErbB2, have been shown to be associated with a variety of
cancers (Blume-Jensen and Hunter, 2001). The EGFR and its
signaling pathway has been well studied with respect to
protein–protein interactions, and for the main players in the
pathway, their interaction sites have been mapped. The three
other members of the ErbB family are less well studied
(Olayioye et al, 2000), although interaction partners have also
been identiﬁed for a number of phosphotyrosine residues in
ErbB2, ErbB3 and ErbB4. Ageneral model of how this receptor
family integrates different signals from different stimuli
through unique and redundant binding sites will be crucial
to our understanding of the diverse biological roles of this
receptor family. Therefore, systematic mapping of protein
interaction sites of whole protein families and motif classes
combined with unbiased protein detection is necessary.
Using a recently developed quantitative proteomics tech-
nology for determining protein–protein interactions (Schulze
and Mann, 2004), we here present results of a ﬁrst systematic
proﬁling of phosphotyrosine-dependent interaction sites on
the ErbB-receptor family. Our screen resulted in novel and
global insights into speciﬁcity and distribution of protein
interaction sites by giving a broad picture of the direct
interaction partners of all phosphotyrosine residues of the
ErbB family members. The peptide–protein interaction screen
turned out to be extremely speciﬁc in the detection of primary
interaction partners, and revealed that each of the receptors
has distinct patterns of binding partners, indicating distinct
roles in signaling events. Strikingly, EGFR and ErbB4 show
high similarities in their phosphotyrosine interaction partners,
suggesting integrative roles in signaling pathways of their
respective ligands.
Results
Detection of protein–protein interactions has previously been
a balance between speciﬁcity (background reduction) and
afﬁnity (detection of weak interactions). Recently, the intro-
duction of stable isotope labeling, to distinguish speciﬁc from
unspeciﬁc interaction partners (Blagoev et al, 2003; Ranish
et al, 2003), has enabled detection of weak binders in the
presence of high levels of background proteins (see below).
Based on this principle, we have developed a proteomic screen
for peptide motif-based interactions (Schulze and Mann,
2004). Using synthetic peptide pairs in phosphorylated and
unphosphorylated form, pull-down experiments are per-
formed to enrich speciﬁc binding partners to the phosphory-
lated bait peptides. These proteins are subsequently identiﬁed
and quantiﬁed by mass spectrometry. In this study, by further
method development, we greatly increased the throughput of
the analysis allowing us to proﬁle the entire phosphotyrosine
interactome of the ErbB-receptor family.
Improvements and scale-up of the peptide–protein
interaction screen
The ErbB family contains a total of 89 cytosolic tyrosine
residues. In order to carry out a systematic analysis of binding
partners to the corresponding phosphotyrosine motifs, the
proteomic peptide–protein interaction screen had to be
optimized and streamlined. In the process of scaling up the
method,desthiobiotininsteadofbiotinwasusedasthetagging
reagentduring peptidesynthesis. Desthiobiotinylatedpeptides
were then immobilized on streptavidin-coated magnetic beads
(Dynabeads MyOne Streptavidin), and after incubation with
cell lysate, bait peptides and proteins bound to them were
eluted with biotin. Bait peptides were removed from the
reaction by precipitation of proteins. As a consequence, eluted
proteins did not have to be separated over SDS–PAGE prior to
analysis by mass spectrometry and were directly trypsin-
digested in-solution. This eliminated the time-consuming in-
gel digestion step and reduced the number of LC–MS/MS
experiments from at least six to one run per pull-down
experiment. Furthermore, in-solution digests are more readily
automatable and can be performed at a scale of hundreds or
thousands. Thus, the improved method allows interaction
proﬁling at a system-wide scale.
In the later part of the study, we employed a linear ion trap
Fourier transform mass spectrometer (LTQ-FT, ThermoFinni-
gan). This instrument has signiﬁcantly higher sequencing
speed and peptide mass accuracy, which resulted in signiﬁ-
cantly higher quality data.
Systematic analysis and general comparison
Here, we present results of the ﬁrst modiﬁcation-dependent
protein interaction study involving systematic proﬁling of
binding sites of a whole receptor subfamily. For many
receptors, the physiological phosphorylation sites are not well
documented, and algorithms for their prediction are still
limited. The relatively high throughput of our screen allowed
systematic study of all tyrosine sites, without making prior
assumptions about the baits or their potential interaction
partners. In particular, we wanted to demonstrate that the
throughput of the method is sufﬁciently high, so that no
information about the phosphorylation status (i.e. in vivo
phosphorylated or not) needed to be taken into account.
Therefore, we chose to study potential interaction partners to
all cytosolic tyrosine residues of the ErbB-receptor family in
their phosphorylated form in a systematic and unbiased
approach. Altogether, we analyzed all 94 pairs of synthetic
singly phospho-, nonphospho- and doubly phosphopeptides
to a total of 89 cytosolic tyrosine residues in the four receptors
EGFR, ErbB2, ErbB3 and ErbB4.
For a total of 25 phosphotyrosines, a single interaction
partner was found, and for 13 additional tyrosine residues, we
found more than one interacting protein (Table I). Not
surprisingly, 49 out of the 89 investigated tyrosine residues
did not have an interaction partner to their phosphorylated
form. Most of the tyrosine residues without interaction
partnersarelocatedinandaroundthekinasedomain,whereas
theresiduesthat interactedwith speciﬁcpartnersaccumulated
at the C-terminal regions of the receptors. Strikingly, all
bindingpartnerswith a signiﬁcant ratioinourassay had either
an SH2 or a PTB domain.
An overviewof the distribution of theinteractionpartnersof
the different members of the ErbB-receptor family shows clear
differences between individual receptors, but also a large
overlap (Figure 1, Supplementary Table I). EGFR is the family
member with most interaction partners and the highest
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partner. ErbB3 is characterized by a large number of binding
sites for phosphatidylinositol-3-kinase (PI3K), while ErbB2
hasonlyfewinteractionpartnerswithShcasthemostfrequent
one. ErbB4 and EGFR have a variety of phosphotyrosines that
bind Grb2, or Grb2 and Shc. EGFR and ErbB4 have a greater
diversity of interaction partners than ErbB2 and ErbB3. All
interactions found in this study have been submitted to the
public Molecular INTeraction database (Zanzoni et al, 2002).
Interactions mediated by speciﬁc peptide motifs
ErbB family members show high homology in the kinase
domain (59–81% identity), whereas the C-terminal domains
Table I The number of cytosolic tyrosine residues of each receptor analyzed and the number of residues to which none, one or more than one interacting protein was
found
EGFR ErbB2 ErbB3 ErbB4
Total number of cytosolic tyrosines 20 19 23 27
No interactions 8 (40%) 11 (57%) 14 (60%) 16 (59%)
One interaction partner 6 7 8 7
More than one interaction partner 6 (30%) 1 (5%) 1 (4%) 4 (14%)
Number of different binding partners 9 4 4 8
Figure 1 Summary of systematic interaction proﬁling of the ErbB-receptor tyrosine family. All cytosolic residues of the ErbB-receptor family were used in pull-down
assays. The interaction partners found are indicated by symbols. The kinase domain of the receptors is designated as an oval. Underlined and colored tyrosine residues
mark identical sequence regions between different receptors; regions around colored residues show strong homology between receptors. Most interaction partners to
tyrosine residues are found at the C-terminal end outside the kinase domain. The EGFR has multiple interaction partners, and several binding sites for Grb2. ErbB2 has
few interaction partners; of them Shc is the most common. ErbB3 interacts mainly with P13-Kinase subunit p85, and ErbB4 again shows a diversity of interaction
partners, also with several binding sites for Grb2. Receptors are not drawn to scale. The dimerization is indicated by EGFR dimer. Residues are labeled according to the
full-length sequence of each of the receptors.
ErbB receptor phosphotyrosine interactome
WX Schulze et al
& 2005 EMBO and Nature Publishing Group Molecular Systems Biology 2005 3are more divergent (11–25% identity). ErbB3 was the receptor
showing the weakest homology to the other three receptors.
Nevertheless, characteristic sequences around two tyrosine
residues are identical in all four receptors: tyrosines Y900 of
EGFR,Y908ofErbB2,Y897ofErbB3andY906ofErbB4,allare
embedded in the sequence SDVWSYGVTVW; and tyrosine
Y944 of EGFR, Y952 of ErbB2, Y941 of ErbB3 and Y950 of
ErbB4, all have the identical sequence CTIDVYMIMVK
(underlined and color coded in Figure 1). Tyrosine 944 of the
EGF-receptor is phosphorylated by Src-kinase (Stover et al,
1995). To both of these shared tyrosine-containing sequences
no interaction partners were found, suggesting that these
sequences are conserved for structural functions or that they
mediate other types of effects. Furthermore, two pairs of
phosphotyrosine-containing sequences are identical in EGFR
and ErbB2. One of these pairs (pY764 in EGFR and pY772 in
ErbB2) has no interaction partner and the other (pY10l6 in
EGFR and pY1023 in ErbB2) mediates interaction with PTP-2c.
In addition, the protein sequence around pY978 in EGFR and
pY984 in ErbB4 is identical, and in our experiments, binds
STAT5 and PTP-2c when phosphorylated.
Besides these identical sequences, the ErbB-receptor family
also has a highly conserved region around Y915 (EGFR), Y923
(ErbB2), Y912 (ErbB3) and Y921 (ErbB4), to which no
interaction partner was found. Similar to Y944, Y915 was also
shown to be a Src-kinase phosphorylation site in EGFR (Stover
et al, 1995). Two other conserved regions are around Y1197
(EGFR), Y1248 (ErbB2) and Y1284 (ErbB4), as well as around
Y727 (EGFR), Y735 (ErbB2) and Y733 (ErbB4). All six
corresponding phosphopeptides showed speciﬁc interactions
to Shc. It is interesting to note that ErbB3 clearly differs from
theotherthreereceptorswithrespecttoitsinteractionpartners
and conserved regions around tyrosine residues.
Interaction of phosphotyrosine peptides with Grb2, Shc or
PI3K were dependent on speciﬁc consensus sequences that
have been well documented (Songyang et al, 1994; Yan et al,
2002; Pawson, 2004). The protein Shc, which contains a PTB-
domain and an SH2-domain, was found to bind to two
different consensus sequences. The majority of Shc-binding
sites conformed to the typical N-P-X-pY recognition motif for
the PTB domains (Gustafson et al, 1995). However, an
alignment of the sequences around ﬁve Shc-binding sites
revealed no conserved N-terminal motif. Instead, we found a
consensus sequence pY-[KR]-X-[LI] involving a basic residue
neighboring the phosphotyrosine and a hydrophobic residue
at position þ3 (Figure 2). Since PTB domains have recogni-
tion sequences N-terminal to pY and SH2 domains have
C-terminal binding motifs (Yaffe, 2002), Shc is likely to bind
these bait peptides through its SH2 domain. A consensus
binding motif for the Shc SH2-domain of pY-f-X-[LI], with
strongest selection on the position þ3 has been described in
pool-sequencing experiments (Songyang et al, 1994). How-
ever, our results indicate that the strong selection of position
þ3 alone comprising the motif pY-X-X-[LI] is not sufﬁcient to
specify binding of endogenous Shc, as Shc did not bind to
pY915,pY978ofEGFR,pY8O3,pY923ofErbB2,pY912,pY975,
pY1307 of EbB3 or pY921, pY984 of ErbB4, which have a pY-X-
X-[LI] sequence. Supporting evidence for our motif also comes
from experiments that demonstrated binding of recombinant
SH2 domain of Shc to phosphopeptides containing the pY-
[KR]-X-[LI]sequencearoundpY727 andpY998of EGFR(Ward
et al, 1996).
Grb2wasalsofound to bindsequences that deviate fromthe
strict target sequence pY-X-N. Our experiments suggest the
moregeneralizedconsensusmotifpY-[fQ]-[NQFDK],wheref
is a hydrophobic residue. Binding of Grb2 to motifs deviating
from the pY-X-N sequence has previously been noted
(Songyang et al, 1994; Ward et al, 1996). To describe Grb2
binding preferences, we compared ion intensities in extracted
ion chromatograms of identical tryptic peptides of Grb2 from
pull-down experiments with different phosphotyrosine resi-
dues (Figure 3). For the same mass spectrometric conditions,
peptide ion signals from the same tryptic peptide in different
experiments are indicative of the abundance of these peptides
Figure 2 Binding motifs of the major interaction partners of the ErbB-receptor
family. Consensus motifs for binding of Grb2, Shc and P13-Kinase are
presented. Sequences shaded in black are common to the majority of all aligned
sequences. Residues shaded in red denote essential residues for PTB-domain
bindingofShc, whilegreen shadesindicate Grb2 binding sites.Residues shaded
in blue indicate a motif for SH2-domain binding of Shc. Yellow residues mark
essential amino acids in the binding motif for the SH2 domain of P13K. The
binding motif for the PTB domain of Shc is N-P-X-pY. The residue N at position
 3 is essential, whereas the residue P at position  2 can also be replaced.
Besides the known Grb2-binding motif pY-X-N, ﬁve binding sites were found for
Grb2, which did not contain an N in position þ2 after the phosphotyrosine. A
binding target for the SH2 domain of Shc was found to contain pY-[KR]-X-f. The
binding motif for P13-Kinase subunit p85 is pY-X-X-M.
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Correlation Proﬁling (Andersen et al, 2003). Those bait
peptides containing an asparagine residue at position þ2 led
to identiﬁcation of Grb2 peptides with high ion intensities.
This correlates with the strong binding of Grb2 to the pY-X-N
motif. In contrast, bait peptides without asparagine at position
þ2 resulted in the identiﬁcation of tryptic peptides with
signiﬁcantly lower ion intensities (Figure 3). Nevertheless, in
all cases, Grb2 was identiﬁed as a speciﬁc binding partner to
the bait peptide, and these results were conﬁrmed by Western
blots (insets in Figure 3). Furthermore, our ﬁndings are in
agreement with in vitro studies of binding afﬁnities of
synthetic peptides to the recombinant SH2 domain of Grb2
(Ward et al, 1996).
In addition to direct binding of Grb2 to phosphotyrosine
residues of receptor kinases, Grb2 can also be recruited to the
receptor by binding to Shc when Shc is tyrosine phosphory-
lated as a result of receptor stimulation. Phosphorylation of
Shc results in binding of Grb2 to the phosphorylated tyrosine
of Shc via its SH2 domain. We found that ﬁve bait
phosphopeptides had Grb2 and Shc as common binding
partners. However, in all ﬁve cases, the bait peptide contained
overlapping binding motifs for Grb2 and Shc (see also inset in
Figure 3). Furthermore, the experiments were carried out in
cells that were not especially stimulated with growth factor
(even though they were grown in the presence of serum).
Thus, most signal-dependent multi-protein complexes are not
present and binding partners are not activated (phosphory-
lated). Therefore, the identiﬁcation of Grb2 in our pull-down
experiments is most likely due to direct binding and not
indirect binding as an interaction partner of Shc. For the above
reasons, we believe that our experiments generally yield the
direct or primary phosphotyrosine interactome rather than
protein complexes.
Y-E-Y motifs of ErbB3 and the role of double
phosphorylation
ErbB3 contains three pairs of tyrosine residues that are
separated by one glutamic acid residue comprising Y1197
and Y1199, Y1222 and Y1224, as well as Y1260 and Y1262.
These Y-E-Y motifs were not found in any of the other ErbB-
receptors, suggesting that these regions may perhaps have
speciﬁc interaction partnersalsointhe doubly phosphorylated
state, or that double phosphorylation enhances or abolishes
interaction of proteins in the singly phosphorylated peptides.
To investigate this question, we used the Y-E-Y regions as bait
peptides in unphosphorylated, singly phosphorylated and
doubly phosphorylated states, with cell lysates that were
metabolically labeled with either
12C6-arginine (Arg0),
13C6-
arginine (Arg6) or
15N4
13C6-arginine (Arg10) and used in
pull-down experiments with unphosphorylated, singly phos-
phorylated and doubly phosphorylated bait peptides.
The results show that there are clear binding partners for
each of the singly phosphorylated bait peptides of the Y-E-Y
motifs (Figure 4). All three Y-E-Y motifs contain a binding site
for PI3K at the ﬁrst tyrosine residue (Y1197, Y1222 and Y1260;
pY-E-Y), and two motifs contain a binding site for Grb2 at the
second tyrosine residue (Y1199 and Y1268; Y-E-pY). The Y-E-Y
motif with phosphorylated tyrosine residue Y1224 (Y-E-pY)
did not result in speciﬁc binding of any protein. PI3K, as well
as Grb2, also interacted with the doubly phosphorylated bait
peptides. However, Grb2 interaction was weaker with the
doubly phosphorylated bait peptides, compared to the inter-
action with the singly phosphorylated peptide, including the
Grb2 binding site. Apparently, the doubly phosphorylated
regions did not have characteristic speciﬁc interaction
partners. Since both tyrosine residues are very close together,
only one of the two possible interaction partners can bind at a
time, and it remains open if the doubly phosphorylated form
actually occurs in vivo.
Direct interaction of EGFR and ErbB4 with STAT5
Thesystematicproﬁlingofinteractionpartnersnotonlyallows
a global view of interaction sites, but also reveals important
detailed information that can be exploited further for the
understanding of signaling processes, as will be illustrated
with the example of STAT5 binding to EGFR. STAT5 is a
transcription factor that is rapidly activated upon EGF
Figure 3 Interaction strength of Grb2 binding sites. Ion intensities of extracted
ion chromatograms of identical tryptic peptides of Grb2, which were identiﬁed in
pull-down experiments using different phosphotyrosine containing bait peptides.
ThetwoaminoacidsC-terminaltothebaitphosphotyrosineareindicated.(A)Ion
intensities of tryptic Grb2 peptides in pull-downs with phosphotyrosine baits of
EGFR. (B) Ion intensities of tryptic Grb2 peptides in pull-downs with
phosphotyrosine baits of ErbB4. Insets show abundance of interaction partner
by Western blot.
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phosphorylation combinations were determined. Results are shown for the two tyrosines around Yl 197 and Yl 199. (A) MS spectra of a tryptic peptide of Filamin A, an
unspeciﬁc binding protein as indicated by the same ion intensity when precipitated by the nonphosphorylated, singly phosphorylated and doubly phosphorylated bait.
(B) MS spectra of a tryptic peptide of Grb2. Grb2 binds to pY-E-pY and Y-E-pY. (C) MS spectra of a tryptic peptide of PI3-Kinase. PI3-Kinase subunit p85 binds to
doubly phosphorylated peptide and pY-E-Y. No protein was found to bind speciﬁcally to the doubly phosphorylated peptides.
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in the regulation of gene transcription. Experiments with
truncated EGFR clones suggested that the region between
tyrosineresidueY0978andY0998wasnecessaryforactivation
of STAT5 (Xia et al, 2002). However, it remained unclear
whether this proposed interaction was direct or through a
multiprotein complex. Systematic interaction proﬁling of all
tyrosine residues of the ErbB-receptor family revealed STAT5
as a speciﬁc interaction partner to the phosphorylated bait
peptides Y978 and Y998 of the EGF receptor and Y984 of
ErbB4.Weconﬁrmed thedirect interaction ofSTAT5 andEGFR
by immunoprecipitation. When EGFR was immunoprecipi-
tated from whole-cell lysates of cells under normal growth
conditions (basal stimulation in 10% FBS), STAT5 was
identiﬁed by Western blot and vice versa (Figure 5). To further
conﬁrm this ﬁnding, we added synthetic phosphorylated
peptides pY978 and pY998 to the immunoprecipitation
reaction, which resulted in reduced STAT5 detection after
EGFR immunoprecipitation and in reduced EGFR detection
after STAT5 immunoprecipitation. The unphosphorylated
counterparts of these peptides had no inﬂuence on the
immunoprecipitation reactions (Figure 5A). Figure 5B shows
that the interaction of STAT5 depended on EGFR phosphoryla-
tion, which peaked after two minutes of EGF stimulation, and
that normal growing HeLa cells also have a basal level of
phosphorylated EGFR.
Dynamics of tyrosine phosphorylation after EGF
stimulation
To correlate our ﬁndings with in vivo phosphorylation of the
receptor, we directly analyzed the kinetics of phosphorylation
of several sites upon EGF stimulation by mass spectrometry.
Phosphopeptides of immunoprecipitated EGFR were analyzed
by LC–MS/MS after different times of stimulation with EGF.
For these experiments, different cell populations were com-
pletely SILAC labeled with either Arg0, Arg6 or Arg10. Arg0
populations were left unstimulated, Arg6 populations were
stimulated for either 2 or 4min, and Arg10 populations were
stimulated for eight or 15min. Ratios between tryptic
phosphopeptides in their Arg0, Arg6 and Arg10 forms in the
combined immunoprecipitations allowed one to monitor the
abundance of these tryptic phosphopeptides as a function
of time after EGF stimulation (Blagoev et al, 2004). In this
experiment, we identiﬁed a novel EGFR phosphorylation site
by the tryptic peptide containing the phosphorylated tyrosine
residue Y998 (Figure 6A). In total, tryptic peptides to six
phosphorylation sites were analyzed (Figure 6B). Peptides of
phosphorylated Y1110, Y1172 and Y1197 showed highest ratios
at 2–4min of stimulation, and these ratios decreased with
longer EGF stimulation. In contrast, Src-kinase phosphoryla-
tion site Y869 displayed a decrease in ratio at 4min of
stimulation, which was accompanied byan increase in ratio of
the nonphosphorylated tryptic peptide. The novel phosphor-
ylation site at Y998 displayed a gradual increase in ratio over
15min of stimulation, and the phosphorylation site at Y801
was maximally activated as late as 8min after start of EGF
stimulation (Figure 6B). However, in interpreting the kinetics
of such curves, it has to be kept in mind that the amount of
EGFR immunoprecipitated by the phosphotyrosine antibody
will depend on the total tyrosine phosphorylation of the
receptor in addition to the phosphorylation of the site under
investigation.
These results show that different phosphorylation sites
show different phosphorylation dynamics after stimulation,
reﬂecting distinct temporal roles in signaling. Interestingly,
these differences in phosphorylation dynamics correlate with
the interaction partners identiﬁed for each of these sites. The
autophosphorylation sites at Y1110 and Y1197 display rapid
phosphorylation with a maximum after 4min and they have
the same set of interaction partners (Grb2 and Shc). The novel
phosphorylation site at Y998 is increasingly phosphorylated
over 15min, and interacts with STAT5, PTP-2c, Shc, Crk, and
the phosphotyrosine kinase Src or Csk (Cole et al, 2003),
which could not be distinguished based on the observed
tryptic peptides. Crk was immunoprecipitated with EGFR in a
phosphorylation-dependent manner (Figure 5B). In contrast,
the phosphorylation sites at Y801 and Y869 showed distinct
phosphorylationkinetics,buthadnointeractionpartnerinour
assay.
Figure 5 Co-immunoprecipitation of STAT5 and EGFR. (A) In co-
immunoprecipitation experiments, EGFR was detected by Western blot (WB)
in immunoprecipitations (IP) with STAT5, and STAT5 was detected in
immunoprecipitationsofEGFR.Co-immunoprecipitationwasreducedbyaddition
of phosphorylated peptides pY978 and pY998 of EGFR. There was no effect
when these peptides were added in their nonphosphorylated form as control
(Y978 and Y998). In addition, equal amounts of EGFR and STAT5 were
immunoprecipitated, as shown by the IP with STAT5, WB with STAT5 and the IP
with EGFR, WB with EGFR, respectively. The experiments were performed on
HeLa cells growing in 10% FBS. (B) Phospho-EGFR, STAT5 and Crk after
immunoprecipitation of EGFR from normal growing HeLa cells (basal), serum-
starved cells for 14h (starved) and EGF-stimulated cells for 2 and 10min. The
antibody was used for IP and WB of EGFR against codons 998–1022, while the
antibody against phospho-EGFR was directed against pYl 197 of EGFR. STAT5
antibody is directed against the C-terminal domain of Stat5b, but recognized
isoforms STAT5a/b, and Crk antibody is directed against the N-terminus of Crk.
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Speciﬁc protein–protein interactions are not only involved in
the formation of stable multimeric complexes, but are
important for a large number of rather short-term associations
of proteins during signaling. Kinase and substrate need to
interact, and temporary complexes are formed by means of
scaffolding and adaptor proteins (Robinson and Bonifacino,
2001; Pawson, 2004). Knowing the binding partner to a
phosphorylation site deﬁnes the role of that particular
modiﬁcation during signal transduction. Apart from resolving
interactions to speciﬁc binding sites on different signaling
proteins, an overall picture of the distribution of binding sites
for interacting proteins mayalso lead to generalconclusions of
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Figure 6 Phosphorylation dynamics of EGFR. (A) MS–MS fragmentation spectrum of the tryptic peptide MHLPSPTDSNFYR and MHLPSPTDSNF[pY]R of EGFR
showing phosphorylation of tyrosine 998. (B) Time course of phosphorylation at six different tyrosine residues of the EGFR upon EGF stimulation. Ratios of peak
intensities after EGF stimulation versus no stimulation are shown. Tyrosine residues Y1110, Y1172 and Y1197 are autophosphorylation sites, tyrosine Y869 is
phosphorylated by Src kinase, and tyrosine Y998 and Y801 are novel phosphorylation sites.
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taken in this study is thus complementary to other proteomic
approaches in which whole signaling complexes are identiﬁed
(see, e.g., Blagoev et al, 2003).
As signaling events are often characterized by phosphoryla-
tion of receptors and downstream interaction partners, the
peptide–protein interaction screen (Schulze and Mann, 2004)
was further developed for high sample throughput and used to
map the primary binding partners of phosphorylated tyrosine
residues of the ErbB-receptor family. Individual members of
this family have in the past been studied with respect to
interaction partnersofselected residues usingphosphopeptide
competition analysis, receptor mutants and coimmunopreci-
pitation(Margolisetal, 1990;Birgeetal, 1992;Fedietal, 1994;
Prigent and Gullick, 1994; Lombardo et al, 1995; Sorkin et al,
1996; Keilhack et al, 1998; Hellyer et al, 2001; Yarden and
Sliwkowski,2001;Moroetal,2002;Blagoevetal,2003).Inthis
study, we take a new approach that allows comparison and
mapping of the primary interaction partners and their binding
sites in a single, comprehensive and unbiased system; that is,
we do not need to make any assumptions about likely baits or
interaction partners.
Speciﬁcity and sensitivity
The fact that all binding partners identiﬁed contained either
SH2- or PTB-domains emphasizes the speciﬁcity of signal
transduction modules (Pawson and Nash, 2003), combined
with the observation that phosphotyrosines that were not
expected to have binding partners did not show any proteins
with signiﬁcant ratios. This is in contrast to other protein–
protein interaction screens, especially in large-scale format
(von Mering et al, 2002), and we conclude that assay is
extremely speciﬁc and capable of conﬁrming known binding
motifs and detecting new target sequences.
Our screen resulted in identiﬁcation of the vast majority of
expected direct interaction partners of the ErbB family that
bind through phosphotyrosines. Among the few exceptions
was PLC-g, which we were unable to ﬁnd as an interaction
partnerof Y1197 of the EGF receptor. This interaction has been
described using immunoprecipitations and in vitro phospho-
peptide competition and binding assays with cloned domains
(Margolis et al, 1990; Rotin et al, 1992). The peptide–protein
interaction assay as such is capable of identifying PLC-g, since
we previously described such an interaction using an IRS4
phosphopeptide as bait (Hinsbyet al, 2004). We also could not
ﬁnd the interaction of Y1197 with SHIP1 (Keilhack et al, 1998),
or of Y1248 of ErbB2 with Chk (Zrihan-Licht et al, 1998).
Binding constants of SH2 domains to phosphotyrosines are
in the range of 50–500nM (Pawson, 2004), while binding
constants of certain PTB domains to the respective bait
peptides can be as low as 2mMt o1 0 mM( Y a net al, 2002).
The peptide–protein interaction screen was validated for
binding constants as low as at least 5mM (Schulze and Mann,
2004), but it is likely to work with much lower afﬁnity
interactions, too. Thus,we believe that the negative results are
unlikely to be caused by low afﬁnity of the interactions.
However, some interactions may not only be motif-dependent,
but also require cooperative binding or activation of the
binding partner.
In this study, we identify Grb2 as a speciﬁc binding partner
to tyrosines Y1199 and Y1268 of ErbB3. Other studies have
identiﬁed Grb7 as a speciﬁc binding partner to those tyrosine
residues using immunoprecipitation and Western blots as
detectionmethod,butassayswithsyntheticpeptidesindicated
that Grb2 can also bind to Y1199 and Y1268, but with a lower
afﬁnity (Fiddes et al, 1998). We have not identiﬁed Grb7 at all
in the peptide pull-downs using whole-cell lysate and could
not detect Grb7 expression in HeLa cells by Western blotting
(data not shown). Therefore, the differences in interaction
partner may be due to the use of a different cell type. This
example illustrates that the results of our assay depend on
expression of the binding partner in vivo, and may be different
for different cell types.
Finally, some proteins have previously been reported to
interact with EGFR (van Delﬁ et al, 1997), such as EPS15
(Schumacher et al, 1995). In our study, we see EPS15 in pull-
downs with a number of bait peptides, but always with a ratio
of one to one, indicating no direct binding to the bait peptides.
This would in any case be expected since EPS15 has no SH2 or
PTB domain, and ratheris recruitedto EGFR in a largerprotein
complex.
Redundancy of binding sites
With very few exceptions, each of the proteins recruited to
phosphotyrosines on the ErbB family had more than one
binding site, although sometimes with different afﬁnities. For
example, EGFR has six binding sites for the adapter protein
Grb2, and ErbB4 has ﬁve, each with different binding strength
(see Figure 3 and Ward et al, 1996). PI3K is the sole binding
partner to six tyrosines of ErbB3 and one in ErbB4. This
redundancy allows combinatorial control of downstream
effector pathways in several ways. Different upstream
signals can induce different phosphorylation patterns on ErbB
receptors—for example, in the case of EGF versus TGFa
stimulation of EGFR (Guo et al, 2003). The combination of
these different phosphorylation patterns with the different
binding afﬁnities allows a different cast of effector molecules
to be assembled at the receptor. A second level of combinator-
ial control is the formation of different homo- or heterodimers,
depending on the stimulatory condition (Olayioye et al, 1998;
Hynes et al, 2001). Studies of cells with differential over-
expression of ErbB family members in various combinations
revealed that binding of ErbB2 to Shc, PI3K or Grb2 was
dependent on the mode of activation, and that receptor
phosphorylation also was dependent on the dimerization
partner (Goehler et al, 2004). Thus, the interaction partners
Grb2, Shc or PI3K may only interact with a speciﬁc
phosphotyrosine under a given cellular condition, and with a
different one under another stimulus or dimerization state.
The redundancy in binding sites for speciﬁc adapter proteins
thus may be essential for integration of different stimuli and
the coordinated transduction of this information to down-
stream pathways and to ensure, in one way or another, the
binding/activation of these very important signaling switches.
However, it has to be kept in mind that some phosphorylation
sites may be active only under veryspeciﬁc conditions in vivo,
and some sites analyzed in our systematic screen arelikely not
be phosphorylated under any conditions.
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In this study, we clearly identiﬁed STAT5 as a direct interaction
partner to EGFR (Y978 and Y998) and ErbB4 (Y984). It was
previously shown that Src-phosphorylated tyrosine residue
Y869 is essential for activation of STAT5b, but does not
mediate the interaction itself (Kloth et al, 2003). EGF
stimulation and subsequent phosphorylation of EGFR at
tyrosine Y978, Y998 and Y869 (see Figure 6B) would then
lead to recruitment and activation of STAT5, which subse-
quentlyactivatestranscription.OurﬁndingthatErbB4alsohas
a binding site for STAT5 is consistent with the observation that
dimerization of ErbB2 and ErbB4 lead to activation of STAT5b
(Olayioye et al, 1999) and that ErbB4 signaling is required for
STAT5 activation during lactation (Jones et al, 1999). This is a
further example showing that signaling through EGFR and
ErbB4 can activate similar downstream processes in response
to their different ligands.
Inaseparateexperiment,wehavedeterminedtheactivation
proﬁles of several tyrosine phosphorylation sites in response
toEGF.Wefoundthatactivationkineticscancorrelatewith the
type of interaction partner. While this experiment was limited
in the number of sites analyzed, it clearly shows how
integration of in vivo kinetics with a knowledge of binding
partners can add more functional information of phosphoryla-
tion sites and interaction partners.
Implications for signaling roles of different ErbB
family members
This study reveals striking similarities between EGFR and
ErbB4 with respect to their interaction partners and the
distribution of speciﬁc binding sites at the C-terminal end of
the receptors. EGFR and ErbB4, the two fully functional
receptor tyrosine kinases of the family, are also the two
receptors that were found to have the greatest diversity of
interaction partners. Both receptors contain redundant bind-
ing sites for Grb2, and both receptors were found to bind
STAT5. However, EGFRwasunique in having a binding site for
Cbl, which did not interact with any of the other receptor bait
peptides.
It is well known that EGFR functions as an integration
site for different stimuli (Hackel et al, 1999; Zwick et al,
1999). Thus, redundancy of binding sites and a great
diversity of different binding partners is not unexpected.
Our data suggest that ErbB4 may serve a similar role
during signaling through neuregulin-induced pathways. This
idea is supported by ﬁndings of overexpression studies, in
which EGFR dimerizes preferably with ErbB2 and ErbB3,
while ErbB4 dimerizes with ErbB2 and ErbB3, but to a
lesser extent with EGFR (Olayioye et al, 2000). In this
respect, it should be kept in mind that ErbB2 has a
nonfunctional extracellular ligand-binding domain and is a
common dimerization partner of other members of the ErbB
family (Graus-Porta et al, 1997). In contrast, ErbB3 has an
inactive kinase domain; thus, transphosphorylation in differ-
entheterodimersmayleadtophosphorylationofdifferentsites
in ErbB3.
An evaluation of existing microarray expression data
(Affymetrix human U133A data set, Novartis Foundation)
using hierarchical cluster analysis (Supplementary Figure 1)
shows that EGFR and ErbB4 indeed are rarelycoexpressed and
that ErbB2 and ErbB3 are seldom expressed without either
EGFRorErbB4.Thus,ourdataareconsistentwiththeideathat
EGFR and ErbB4 function as ‘control centers’ and sites of
integration for signaling processes, involving stimulation with
their ligands, EGF and neuregulin, respectively. Furthermore,
the striking difference in interaction partners of kinase-
inactive ErbB3 compared to the other family members may
indicate a speciﬁc role in signaling to the PI3K pathway as part
of heterodimers with EGFR, ErbB4 or ErbB2 in different cell
types or differentiation stages.
Perspective
Thepeptide–proteininteractionscreenintegrateswellwiththe
broader goals of phosphoproteomics. While we have per-
formed a systematic screen of all potential pY sites in this
study, bioinformatic predictions of phosphorylation sites or
experimentally veriﬁed sites could have been taken as a basis
for bait selection. The identiﬁcation of signal-dependent
phosphorylation sites is thus a major experimental goal in
the characterization of signaling networks. The peptide
interaction screen then allows one to directly identify possible
bindingpartnerstotheseidentiﬁedphosphopeptideswithhigh
conﬁdence.
ErbB2 and EGFR are attractive targets for cancer therapy as
they are often overexpressed or mutated in tumors. The drug
Herceptint has been developed as an efﬁcient treatment of
cancer types that depend on overexpression of ErbB2, and
small molecule kinase inhibitors have been directed against
EGFR. Both strategies have the general goal of inhibiting
aberrant signaling. However, many studies show that pertur-
bation of signaling networks can have diverse and unantici-
pated effects. For example, a thorough analysis of Herceptin
action revealed that it did not only affect ErbB2, but also the
expression of EGFR and its downstream ligands (Smith et al,
2004). Theunderstandingof receptor-signaling crosstalkanda
detailed picture of different sites of interaction to downstream
binding partners can be expected to contribute to description
of signaling networks at the systems biology level. Systematic
screens, such as the one performed here, can possibly enable
entirely new ways of identifying interesting drug targets and
potentially make important contributions to therapeutic
research.
Our studies show that different receptors in the ErbB family
clearly differ in their preferred interaction partners, indicating
distinct roles in signaling. Furthermore, modiﬁcation-depen-
dent interaction does not occur at random, but rather requires
characteristic motifs for speciﬁc classes of proteins to interact.
Novel motifs were found for Shc and STAT5 binding.
Importantly, we have shown that the peptide–protein interac-
tionscreencanbeperformedinalarge-scalefashionandthatit
is indeed a suitable method to obtain a broad picture of shared
and distinct interaction partners of a whole protein family. In
the future, with further improvements in mass spectrometric
performance, streamlining and automation, the screen can be
applied system-wide to essentially all signaling proteins and
their substrates.
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Cell culture
Human HeLa cells were grown in arginine-deﬁcient Dulbecco’s
modiﬁed Eagle’s medium (DMEM) with 10% dialyzed fetal bovine
serum. One cell population was supplemented with normal isotopic
abundance L-12 arginine (Sigma) and L-lysine, and the other with 99%
isotopic abundance
13C6-arginine (Aldrich) and
13C6-lysine, as
described(Ong et al, 2003).Therebyfull labeling of all trypticpeptides
was achieved. In some experiments, cell populations were metaboli-
cally labeled using D4-lysine instead of
13C6-lysine. For studies with
singly and doubly phosphorylated peptides of the Y-E-Y motifs, three
different cell populationswere labeled with
12C6-arginine (Arg0),
13C6-
arginine (Arg6), and
13C6
15N4-arginine (Arg10), resulting in mass
differences of 6 and 10Da to the Arg0 form, respectively. Each cell
population was grown for at least ﬁve passages, encompassing a
minimum of seven population doublings.
For experiments determining phosphorylation kinetics, three
different cell populations were labeled with Arg0, Arg6 and Arg10,
respectively. Prior to stimulation, cells were serum-starved for 18h.
Unlabeled cells were left unstimulated, while two cell populations
labeled with Arg6 were stimulated for two minutes and four minutes,
respectively, and two cell populations labeled with Arg10 were
stimulated for 8min and 15min, respectively. EGF was added to a
ﬁnalconcentrationof200ng/ml.Lysatesofcellsafterdifferenttimesof
EGFstimulationwere combinedas described(Blagoev et al, 2004)and
subjected to immunoprecipitation with a general antibody against
phosphotyrosine residues.
Peptide synthesis and pull-downs
Desthiobiotinylated peptides were synthesized on a solid-phase
peptide synthesizer using amide resin (Intavis, Germany). Peptides
were designed as 15-mers bearing an N-terminal biotin, the tetrapep-
tide linker SGSG (Ward et al, 1996). The identity and purity of the
synthesized peptides was conﬁrmed by mass spectrometric analysis.
Peptidesweresynthesizedaspairsinan‘active’and‘control’form.For
afﬁnity pull-downs, 50nmol of immobilized peptide was added to an
average of 2mg of cell lysate.
Dynabeads MyOne Streptavidint were saturated with biotinylated
peptide prior to incubation with cell lysates. Cells were lysed in 1%
(v/v) Nonident P-40, 150mM sodium chloride, 50mM Tris–HCl pH
7.5, protease inhibitors (Complete Tablets, Roche), and 1mM sodium
orthovanadate as phosphatase inhibitor. An equal amount of protein
was incubated with the respective immobilized peptides at 41C for 4h.
After six rounds of washing with lysis buffer, beads of pull-down pairs
with ‘control’ and ‘phosphorylated’ were combined (Schulze and
Mann, 2004) and bound proteins were eluted using 20mM biotin.
Eluted proteins were precipitated and subsequently digested with
trypsin for LC–MS/MS analysis as described.
Immunoprecipitation
HeLa cells were lysed in 1% (v/v) Nonident P-40, 150mM sodium
chloride, 50mM Tris–HCl pH 7.5, 1mM sodium orthovanadate and
protease inhibitors (Complete Tablets, Roche), and incubated at 41C
with respective primary antibodies. Depending on the host animal of
the antibody, protein-A-sepharose or protein-G-sepharose beads were
added after 2h and incubated for an additional 4h. After three rounds
ofwashes,coprecipitatedproteinswereelutedinsamplebufferforSDS
gel electrophoresis. For peptide competition analyses, 250mg
(125nmol) of phosphorylated or nonphosphorylated peptide was
added to the immunoprecipitation reaction. STAT5 was immunpreci-
pitated with an antibody directed against STAT5a and b isoforms
(Santa Cruz), EGFR was immunoprecipitated with a polyclonal
antibody (Santa Cruz). For immunoprecipitation of tyrosine-phos-
phorylated proteins, we used the 4G10-anti-phosphotyrosine antibody
(Upstate Cell Signaling Technologies).
LC/MS/MS, database searching and quantitation
Eluted proteins were in-solution digested with 1mg trypsin after
reduction in 1mg DTT, alkylationwith 5mg iodoacetamide and dilution
of the sample with 4 volumes of 50mM NH4HCO3. Tryptic peptide
mixtureswerethendesaltedonSTAGEtips(Rappsilberetal,2003)and
loaded onto reversed phase analytical columns for liquid chromato-
graphy(Ishihamaet al,2002). Peptideswereelutedfromthe analytical
column by a multistep linear gradient running from 5 to 30%
acetonitrile in 90min and sprayed directly into the oriﬁce of a
QSTAR-Pulsar quadrupole Time-Of-Flight hybrid mass spectrometer
(PE-Sciex, USA) or a LTQ-FT (Thermo Electron, Germany). Proteins
were identiﬁed by tandem mass spectrometry (MS/MS) by informa-
tion-dependent acquisition of fragmentation spectra of multiple-
charged peptides that were then searched against the human
International Protein Index Database (IPI; http://srs6.ebi.ac.uk) using
the Mascot algorithm (Perkins et al, 1999) with search parameters as
described in (Foster et al, 2003) for QSTAR data and as in Olsen et al
(2004) for LTQ-FT data. For quantitation and spectra validation, the
software MSQuant (http://msquant.sourceforge.net) was used.
Determination of signiﬁcant binding partners
Ratios of labeled to unlabeled forms of each validated tryptic peptide,
and the associated average ratio for the whole protein were obtained
by MSQuant. A plot of the distribution of all protein ratios from one
experiment revealed the highest number of proteins with a ratio of
around one. Those ratios being signiﬁcantly (2s) different from the
averageratioofthe majority(coveringmean7s)ofidentiﬁedproteins
were considered as signiﬁcant. Furthermore, we used crossover
experiments (Schulze and Mann, 2004) in which speciﬁc interaction
partners were required to have inverse ratios compared to the ﬁrst
experiment. In the pull-down experiments, 89–153 proteins were
quantiﬁed. Cutoff thresholds were calculated for each experiment
individually. The range of average ratios for unspeciﬁc binders ranged
from 0.9670.52 to 1.8670.87 in different pull-down experiments.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
Acknowledgements
We thank members of CEBI for critical comments to the manuscript.
SpecialthanksgotoJesperOlsenforsettingupacquisitionmethodsfor
theLTQ-FT.Thisworkwassupportedby‘InteractionProteome’agrant
from the European Commission in the 6th framework program. Work
at CEBI is also supported by grants from the Danish National Research
Foundation.
References
Andersen JS, Wilkinson CJ, Myoru T, Mortensen P, Nigg EA, Mann M
(2003) Proteomic characterization of the human centrosome by
protein correlation proﬁling. Nature 426: 570–574
Birge RB, Fajardo JE, Mayer BJ, Hanafusa H (1992) Tyrosine-
phosphorylated epidermal growth factor receptor and cellular
p130 provide high afﬁnity binding substrates to analyze Crk-
phosphotyrosine-dependent interactions in vitro. J Biol Chem 267:
10588–10595
Blagoev B, Kratchmarova I, Ong S-E, Nielsen M, Foster L, Mann M
(2003) A proteomics strategy to elucidate functional protein–
protein interactions applied to EGF signaling. Nat Biotechnol 21:
315–318
Blagoev B, Ong S-E, Kratchmarova I, Mann M (2004) Temporal
ordering of signaling networks by quantitive proteomics. Nat
Biotechnol 22: 1139–1145
ErbB receptor phosphotyrosine interactome
WX Schulze et al
& 2005 EMBO and Nature Publishing Group Molecular Systems Biology 2005 11Blume-JensenP,HunterT(2001)Oncogenickinasesignalling. Nature
411: 355–365
Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G,
Croughton K, Cruciat C, Eberhard D, Gagneur J, Ghidelli S, Hopf C,
Huhse B, Mangano R, Michon AM, Schirle M, Schlegl J, Schwab M,
Stein MA, Bauer A, Casari G, Drewes G, Gavin AC, Jackson DB,
Joberty G, Neubauer G, Rick J, Kuster B, Superti-Furga G (2004) A
physical and functional map of the human TNF-alpha/NF-kappa B
signal transduction pathway. Nat Cell Biol 6: 97–105
Cesareni G, Panni S, Nardelli G, Castagnoli L (2002) Can we infer
peptiderecognitionspeciﬁcitymediatedbySH3domains?FEBSLett
513: 38–44
Cole PA, Shen K, Qiao Y, Wang D (2003) Protein tyrosine kinases Src
and Csk: a tail’s tale. Curr Opin Chem Biol 7: 580–585
FediP,PierceJH,DiFiorePP,KrausMH(1994)Efﬁcientcouplingwith
phosphatidylinositol 3-kinase, but not phospholipase C gamma or
GTPase-activating protein,distinguishesErbB-3signalingfromthat
of other ErbB/EGFR family members. Mol Cell Biol 14: 492–500
Fiddes RJ, Campbell DH, Janes PW, Siversten SP, Sasaki H, Wallasch
C, Daly RJ (1998) Analysis of Grb7 recruitment by heregulin-
activated erbB receptors reveals a novel target selectivity for erbB3.
J Biol Chem 273: 7717–7724
FosterLJ,deHoogC,MannM(2003)Unbiasedquantitiveproteomics
of lipid rats reveals high speciﬁcity for signaling factors. Proc Natl
Acad Sci USA 100: 5813–5818
Gavin A-C, Bo ¨sche M, Krause R, Grandi P, Marzioch M, Bauer A,
Schultz J, Rick JM, Michon A-M, Cruciat CM, Remor M, Ho ¨fert C,
Schelder M, Brajenovic M, Ruffner H, Merino A, Klein K, Hudak M,
Dickson D, Rudi T, Gnau V, Bauch A, Rybin V, Drewes G, Raida M,
Bouwmeester T, Bork P, Seraphin B, Kuster B, Neubauer G,
Superti-Furga G (2002) Functional organization of the yeast
proteome by systematic analysis of protein complexes. Nature
415: 141–147
Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, Worm U,
Droege A, Lindenberg KS, Knoblich M, Haenig C, Herbst M,
Suopanki J, Scherzinger E, Abraham C, Bauer B, Hasenbank R,
Fritzsche A, Ludewig AH, Buessow K, Coleman SH, Gutekunst CA,
Landwehrmeyer BG, Lehrach H, Wanker EE (2004) A protein
interaction network links GIT1, an enhancer of huntingtin
aggregation, to Huntington’s disease. Mol Cell 15: 853–865
Graus-Porta D, Beerli RR, Daly JM, Hynes NE (1997) ErbB2, the
preferred heterodimerization partner of a ErbB receptors, is a
mediator of lateral signaling. EMBO J 16: 1647–1655
Guo L, Kozlosky CJ, Ericsson LH, Daniel TO, Cerretti DP, Johnson RS
(2003) Studies of ligand-induced site-speciﬁc phosphorylation of
epidermal growth factor receptor. J Am Soc Mass Spectrometry 14:
1022–1031
Gustafson TA, He W, Craparo A, Schaub CD, O’Neill TJ (1995)
PhosphotyrosinedependentinteractionofSHCandinsulinreceptor
substrate 1 with the NPEY motif of the insulin receptor via a novel
non-SH2 domain. Mol Cell Biol 15: 2500–2508
Hackel PO, Zwick E, Prenzel N, Ulirich A (1999) Epidermal growth
factor receptors: critical mediators of multiple receptor pathways.
Curr Opin Cell Biol 11: 184–189
Hellyer NJ, Kim MS, Koland JG (2001) Heregulin-dependent
activation of phosphoinositide 3-kinase and Akt via the ErbB2/
ErbB3 co-receptor. J Biol Chem 276: 42153–42161
HinsbyAM,OlsenJV,MannM(2004)Tyrosinephosphoproteomicsof
ﬁbroblast growth factor signaling: a role for insulin receptor
substrate-4. J Biol Chem 279: 46438–46447
Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, Adams S-L, Millar A,
Taylor P, Bennett K, Boutilier K, Yang L, Wolting C, Donaldson I,
Schandorff S, Shewnarane J, Vo M, Taggart J, Goudreault M,
Muskat B, Alfarano C, Dewar D, Lin Z, Michalickova K, Willems
AR, SassiH, NielsenPA, Rasmussen KJ, Andersen JR, JohansenLE,
Hansen LH, Jespersen H, Podtelejinkov A, Nielsen E, Craword J,
Poulsen V, Sorensen BD, Matthiesen J, Hendrickson RC, Gleeson F,
Pawson T, Moran MF, Durocher D, Mann M, Houge CWV, Figeys D,
Tyers M (2002) Systematic identiﬁcation of protein complexes in
Saccharomyces cerevisiae by mass spectrometry. Nature 415:
180–183
Hynes NE, Horsch K, Olayioye MA, Badache A (2001) The ErbB
receptor tyrosine family as signal integrators. Endocr-Related
Cancer 8: 151–159
IshihamaY,RappsilberJ,AndersenJS,MannM(2002)Microcolumns
with self-assembled particle ﬁts for proteomics. J Chromatogr A
979: 233–239
Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y (2001) A
comprehensive two-hybrid analysis to explore the yeast protein
interactome. Proc Natl Acad Sci USA 98: 4569–4574
Ito T, Tashiro K, Muta S, Ozawa R, Chiba T, Nishizawa M, Yamamoto
K, Kuhara S, Sakaki Y (2000) Toward a protein–protein interaction
mapofthebuddingyeast:acomprehensivesystemtoexaminetwo-
hybrid interactions in all possible combinations between yeast
proteins. Proc Natl Acad Sci USA 97: 1143–1147
Jones FE, Welte T, Fu X-Y, Stem DF (1999) ErbB4 signaling in the
mammary gland is required for lobuloalveolar development and
Stat5 activation during lactation. J Cell Biol 147: 77–88
Keilhack H, Tenev T, Nyakatura E, Godovac-Zinimermann J, Nielsen
L, Seedorf K, Bohmer FD (1998) Phosphotyrosine 1173 mediates
bindingofthe protein-tyrosinephosphatase SHP-1tothe epidermal
growth factor receptor and attenuation of receptor signaling. J Biol
Chem 273: 24839–24846
Kloth MT, Laughlin KK, Biscardi JS, Boerner JL, Parsons SJ,
Silva CM (2003) STAT5b, a mediator of synergism between
c-Src and the epidermal growth factor receptor. J Biol Chem 278:
1671–1679
Landgraf C, Paimi S, Montecchi-Palazzi L, Castagnoli L, Schneider-
Mergener J, Volkmer-Engert R, Cesareni G (2004) Protein
interaction networks by proteome peptide scanning. PLoS Biol 2:
E14
Lombardo CR, ConslerTG, KasselDB (1995) In vitrophosphorylation
of the epidermal growth factor receptor autophosphorylation
domain by c-src: identiﬁcation of phosphorylation sites and c-src
SH2 domain binding sites. Biochemistry 34: 16456–16466
Margolis B, Li N, Koch A, Mohammadi M, Hurwitz DR, Zilberstein A,
Ullrich A, Pawson T, Schlessinger J (1990) The tyrosine
phosphorylated carboxyterminus of the EGF receptor is a binding
site for GAP and PLC-gamma. EMBO J 13: 4375–4380
Moro L, Dolce L, Cabodi S, Bergatto E, ErbaEB, SmeriglioM,TurcoE,
Retta SF, Giuffrida MG, Venturino M, Godovac-Zimmermaim J,
Conti A, Schaefer E, Beguinot L, Tacchetti C, Gaggini P, Silengo L,
Tarone G, Deﬁlippi P (2002) Integrin-induced epidermal growth
factor (EGF) receptor activation requires c-Src and pl3OCas and
leads to phosphorylation of speciﬁc EGF receptor tyrosines. J Biol
Chem 277: 9405–9414
Olayioye M,NeveRM,Lane HA,Hynes NE (2000) TheErbBsignaling
network: receptor heterodimerization in development and cancer.
EMBO J 19: 3159–3169
Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE (1999)
ErbB receptor-induced activation of Stat transcription factors
is mediated by Src tyrosine kinases. J Biol Chem 274:
17209–17218
Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B, Hynes NE
(1998) ErbB-1 and ErbB-2 acquire distinct signaling properties
dependent upon their dimerization partner. Mol Cell Biol 18:
5042–5051
Olsen JV, Ong S-E, Mann M (2004) Trypsin cleaves exclusively
C-terminal to arginine and lysine residues. Mol Cell Proteomics 3:
608–614
Ong S-E, Kratchmarova I, Mann M (2003) Properties of
13C-
substituted arginine in stable isotope labeling by amino acids in
cell culture (SILAC). J Proteome Res 2: 173–181
Pawson T (2004) Speciﬁcity in signal transduction: from
phosphotyrosine-SH2 domain interactions to complex cellular
systems. Cell 116: 191–203
PawsonT,NashP(2003)Assemblyofcellregulatorysystemsthrough
protein interaction domains. Science 300: 445–452
ErbB receptor phosphotyrosine interactome
WX Schulze et al
12 Molecular Systems Biology 2005 & 2005 EMBO and Nature Publishing GroupPerkins DN, Pappin DJC, Creasy DM, Cottrell JS (1999) Probability-
based protein identiﬁcation bysearching sequence databases using
mass spectrometry data. Electrophoresis 20: 3551–3567
Prigent SA, Gullick WJ (1994) Identiﬁcation of c-erbB-3 binding sites
for phosphatidylinositol 30-kinase and SHC using an EGF receptor/
c-erbB-3 chimera. EMBO J 12: 2831–2841
Ranish JA, Yi EC, Leslie DM, Purvine SO, Goodlett DR, Eng J,
Aebersold R (2003) The study of macromolecular complexes by
quantitative proteomics. Nat Genet 33: 349–355
Rappsilber J, Ishihama Y, Mann M (2003) Stop and go extraction tips
for matrix-assisted laser desorption/ionization, nanoelectrospray,
and LC/MS sample pretreatment in proteomics. Anal Chem 75:
663–670
Robinson MS, Bonifacino JS (2001) Adaptor-related proteins. Curr
Opin Cell Biol 13: 443–453
Rotin D, Margolis B, Mohammadi M, Daly RJ, Daum G, Li N, Fischer
EH, Burgess WH, Ullrich A, Schlessinger J (1992) SH2 domains
prevent tyrosine dephosphorylation of the EGF receptor:
identiﬁcation of Tyr992 as the high-afﬁnity binding site for SH2
domains of phospholipase C gamma. EMBO J 11: 559–567
Schlessinger J, Lemmon MA (2003) SH2 and PTB domains in
tyrosine kinase signaling. Sci STKE 2003 Jul 15; 2003(191): RE12.
Review
Schulze W, Mann M (2004) A novel proteomic screen for peptide–
protein interactions. J Biol Chem 279: 10756–10764
Schumacher C, Knudsen BS, Ohuchi T, Di Fiore PP, Glassman RH,
Hanafusa H (1995) The SH3 domain of Crk binds speciﬁcally to a
conserved proline-rich motif in Epsl5 and Epsl5R. J Biol Chem 270:
15341–15347
Smith BL, Chin D, Maltzman W, Crosby K, Hortobagyi GN, Bacus SS
(2004) The efﬁcacy of Herceptin therapies is inﬂuenced by the
expression of other erbB receptors, their ligands and the
activation of downstream signalling proteins. Br J Cancer 91:
1190–1194
SongyangZ,ShoelsonSE,McGladeJ,OlivierP,PawsonT,BusteloXR,
Barbacid M, Sabe H, Hanafusa H, Yi T (1994) Speciﬁc motifs
recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP,
SHC, Syk, and Vav. Mol Cell Biol 14: 2777–2785
Sorkin A, Mazzotti M, Sorkina T, Scotto L, Beguinot L (1996)
Epidermalgrowthfactorreceptor interactionwithclathrinadaptors
is mediated by the Tyr974-containing internalization motif. J Biol
Chem 271: 13377–13384
Stover DR, Becker M, Liebetanz J, Lydon NB (1995) Src
phosphorylation of the epidermal growth factor receptor at novel
sites mediates receptor interaction with Src and p85alpha. J Biol
Chem 270: 15591–15597
Uetz P, Giot L, Cagney G, Mansﬁeld TA, Judson RS, Knight JR,
Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A,
LiY,GodwinB,ConoverD,KalbﬂeischT,VijayadmodarG, YangM,
Johnston M, Fields S, Rothberg JM (2000) A comprehensive
analysis of protein–protein interactions in Saccharomyces
cerevisiae. Nature 403: 623–627
van Delft S, Schumacher C, Hage W, Verkleij AJ, van Bergen en
Henegouwen PM (1997) Association and colocalization of Epsl5
with adaptor protein-2 and clathrin. J Cell Biol 136: 811–821
vonMeringC, KrauseR, SnelB,CornellM,OliverSG,FieldsS,BorkP
(2002) Comparative assessment of large-scale data sets of protein–
protein interactions. Nature 417: 339–403
Ward CW, Gough KH, Rashke M, Wan SS, Tribbick G, Wang JX (1996)
Systematicmappingofpotentialbindingsites forShcandGrb2SH2
domains on insulin receptor substrate-1 and the receptors for
insulin, epidermal growth factor, platelet-derived growth factor,
and ﬁbroblast growth factor. J Biol Chem 271: 5603–5609
Xia L, Wang L, Chung AS, Ivanov SS, Ling MY, Dragoi AM, Platt A,
Gilmer TM, Fu XY, Chin YE (2002) Identiﬁcation of both positive
and negative domains within the epidermal growth factor receptor
COOH-terminal region for signal transducer and activator of
transcription (STAT) activation. J Biol Chem 277: 30716–33023
Yaffe MB (2002) Phosphotyrosine-binding domains in signal
transduction. Nat Rev Mol Cell Biol 3: 177–186
Yan KS, Kuti M, Zuou M-M (2002) PTB or not PTB—that is the
question. FEBS Lett 513: 67–70
Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling
network. Nat Rev Mol Cell Biol 2: 127–137
Zanzoni A, Montecci-Palazzi L, Quondam M, Ausiello G, Helmer-
Citterich M, Cesareni G (2002) MINT: a Molecular INTeraction
database. FEBS Lett 513: 135–140
Zrihan-Licht S, Deng B, Yarden Y, McShan G, Keydar I, Avraham H
(1998)Cskhomologouskinase,anovelsignalingmolecule,directly
associates with the activated ErbB2 receptor in breast cancer cells
and inhibits their proliferation. J Biol Chem 273: 4065–4072
Zwick E, Hackel PO, Prenzel N, Ullrich A (1999) The EGF receptor as
central transducer of heterologous signalling systems. Trends
Pharmacol Sci 20: 408–412
ErbB receptor phosphotyrosine interactome
WX Schulze et al
& 2005 EMBO and Nature Publishing Group Molecular Systems Biology 2005 13